Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

BACKGROUND: Inflammatory mediators may have decisive roles at different stages of tumour development. Mediators within the pentraxin family may be used as strong biomarkers in prognosis of advanced pancreatic carcinoma patients. METHODS: Using pancreatic carcinoma cell lines and gene transfectant, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, S, Ueno, H, Hosoi, H, Hashimoto, J, Morizane, C, Koizumi, F, Tamura, K, Okusaka, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738116/
https://www.ncbi.nlm.nih.gov/pubmed/23828517
http://dx.doi.org/10.1038/bjc.2013.348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738116/
https://www.ncbi.nlm.nih.gov/pubmed/23828517
http://dx.doi.org/10.1038/bjc.2013.348

Ejemplares similares